Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114419924 | 11441992 | 4 | F | 20140817 | 20160815 | 20150901 | 20160818 | EXP | JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-056579 | ELI LILLY AND CO | 66.00 | YR | M | Y | 0.00000 | 20160818 | CN | DE | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114419924 | 11441992 | 1 | PS | CETUXIMAB | CETUXIMAB | 1 | Intravenous (not otherwise specified) | UNK UNK, UNKNOWN | U | 125084 | |||||||||
| 114419924 | 11441992 | 2 | SS | CISPLATIN. | CISPLATIN | 1 | Intravenous (not otherwise specified) | UNK UNK, UNKNOWN | U | U | 0 | ||||||||
| 114419924 | 11441992 | 3 | SS | 5 FU | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | UNK UNK, UNKNOWN | U | U | 0 | ||||||||
| 114419924 | 11441992 | 4 | SS | MONILAC | LACTULOSE | 1 | Oral | UNK UNK, UNKNOWN | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114419924 | 11441992 | 1 | Squamous cell carcinoma of head and neck |
| 114419924 | 11441992 | 2 | Squamous cell carcinoma of head and neck |
| 114419924 | 11441992 | 3 | Squamous cell carcinoma of head and neck |
| 114419924 | 11441992 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114419924 | 11441992 | LT |
| 114419924 | 11441992 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114419924 | 11441992 | Blood alkaline phosphatase increased | |
| 114419924 | 11441992 | Decreased appetite | |
| 114419924 | 11441992 | Dermatitis acneiform | |
| 114419924 | 11441992 | Diarrhoea | |
| 114419924 | 11441992 | Hypokalaemia | |
| 114419924 | 11441992 | Hyponatraemia | |
| 114419924 | 11441992 | Nausea | |
| 114419924 | 11441992 | Neutrophil count decreased | |
| 114419924 | 11441992 | Platelet count decreased | |
| 114419924 | 11441992 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114419924 | 11441992 | 1 | 20140815 | 0 |